Market Share of Expectorant Drugs Industry
The expectorant drugs market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally. Major players in the market are majorly focused on regulatory approval in particular countries as well as product launches to expand their presence in the global market. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known including Merck KGaA, ARPIMED, Perrigo company plc, Sun Pharmaceutical Industries Ltd, Johnson & Johnson Private Limited, Sanofi, Aurobindo Pharma, Genexa Inc., GSK plc, Reckitt Benckiser Group PLC, Cipla Inc., AstraZeneca and among others.
Expectorant Drugs Market Leaders
-
Merck KGaA
-
Perrigo company plc
-
Sun Pharmaceutical Industries Ltd
-
Johnson & Johnson Private Limited
-
Sanofi
*Disclaimer: Major Players sorted in no particular order